Fig. 6.
Effect of anti-Id–IL-2 therapy on the in vivo growth of 38C13 tumors. (A) and (B) represent data of two independent experiments. Syngeneic mice C3H/HeN (n = 10) were inoculated SC with 1 × 103 tumor cells and then treated on the following day by IV injection of various Abs over a period of 5 days. Tumor growth was measured 3 times a week. The percentage of tumor-free animals and the mean tumor volume were calculated. SDs (bars) are only given at day 20 for clarity.
